Clinical Trials Directory

Trials / Completed

CompletedNCT01439399

Analgesic Efficacy of Intravenous Lidocaine and/or Ketamine

Analgesic Efficacy of Intravenous Perfusion of Lidocaine, Ketamine or a Combination After Laparotomy in a Placebo-controlled, Randomized, Double-blind Prospective Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
University of Lausanne Hospitals · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of the present study is to evaluate the analgesic benefit of intravenous lidocaine and ketamine in the perioperative period of abdominal surgery.

Detailed description

Optimal postoperative pain management facilitates rehabilitation immediately after abdominal surgery. Multiple studies have demonstrated that successful postoperative analgesia also reduces perioperative complications and improves patient comfort, thereby providing many benefits for the patient. In acute postoperative pain management intravenous lidocaine and/or ketamine have been advocated because of their morphine-sparing effect.

Conditions

Interventions

TypeNameDescription
DRUGLidocaine,Lidocaine group received an IV bolus of 1.5 mg.kg-1 followed by a continuous infusion of 2 mg.kg-1.h-1 intraoperative and 1.33 mg.kg-1.h-1 for 48 h postoperative.
DRUGKetamineKetamine group received a bolus of 0.5 mg.kg-1, then 0.25 mg.kg-1.h-1 followed by 0.1 mg.kg-1.h-1 for the first 24 h, then 0.05 mg.kg-1.h-1 for the next 24 h.
DRUGassociation ketamine-lidocaineKetamine-lidocaine group received a bolus of 1.5 mg.kg-1 of lidocaine and 0.5 mg.kg-1 of ketamine, a continuous infusion of 1.3 mg.kg-1.h-1 of lidocaine and 0.17 mg.kg-1.h-1 of ketamine was delivered followed by 0.9 mg.kg-1 of lidocaine with 0.08 mg.kg-1.h-1 of ketamine during 48 h, the dose of ketamine being reduced to 0.04 mg.kg-1.h-1 after the first 24 hours.
DRUGPlaceboThe control group (C) received an equal volume of saline 0.9 % during 48 h.

Timeline

Start date
2005-12-01
Primary completion
2007-07-01
Completion
2007-07-01
First posted
2011-09-23
Last updated
2011-09-23

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01439399. Inclusion in this directory is not an endorsement.